STOCK TITAN

Alignment Healthcare (ALHC) president sells 30,000 shares and gifts 21,500

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare, Inc. President Dawn Christine Maroney reported insider transactions in common stock. She sold 30,000 shares in an open-market sale at a weighted-average price of $16.0855 per share under a Rule 10b5-1 plan adopted on 05/22/25. She also made bona fide gifts totaling 21,500 shares to a family member and a charitable donor advised fund. After these transactions, she directly holds 977,313 shares.

Positive

  • None.

Negative

  • None.
Insider Maroney Dawn Christine
Role President
Sold 30,000 shs ($483K)
Type Security Shares Price Value
Gift Common Stock 20,000 $0.00 --
Sale Common Stock 30,000 $16.0855 $483K
Gift Common Stock 1,500 $0.00 --
Holdings After Transaction: Common Stock — 977,313 shares (Direct, null)
Footnotes (1)
  1. Date of Rule 10b5-1 plan adoption: 05/22/25 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.70 to $16.66. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Represents a bona fide gift to a family member. Represents a bona fide gift to a charitable donor advised fund.
Shares sold 30,000 shares Open-market sale of Alignment Healthcare common stock
Weighted-average sale price $16.0855 per share Price for 30,000-share open-market sale
Gifted shares 21,500 shares Bona fide gifts to family member and donor advised fund
Shares after transactions 977,313 shares Direct holdings following sale and gifts
Gift to family member 20,000 shares Bona fide gift of common stock
Gift to donor advised fund 1,500 shares Bona fide gift of common stock
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 05/22/25"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
bona fide gift financial
"Represents a bona fide gift to a family member."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
donor advised fund financial
"Represents a bona fide gift to a charitable donor advised fund."
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maroney Dawn Christine

(Last)(First)(Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600

(Street)
ORANGE CALIFORNIA 92868

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/15/2026S(1)30,000D$16.0855(2)998,813D
Common Stock05/15/2026G(3)1,500D$0997,313D
Common Stock05/18/2026G(4)20,000D$0977,313D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Date of Rule 10b5-1 plan adoption: 05/22/25
2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.70 to $16.66. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
3. Represents a bona fide gift to a family member.
4. Represents a bona fide gift to a charitable donor advised fund.
Remarks:
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney05/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Alignment Healthcare (ALHC) report for Dawn Christine Maroney?

Dawn Christine Maroney reported one open-market sale and two gift transfers of Alignment Healthcare (ALHC) common stock. She sold 30,000 shares and gifted a total of 21,500 shares to a family member and a charitable donor advised fund.

How many Alignment Healthcare (ALHC) shares did the president sell and at what price?

The president sold 30,000 shares of Alignment Healthcare common stock at a weighted-average price of $16.0855 per share. The filing notes the shares were sold in multiple transactions between $15.70 and $16.66 per share.

Were the Alignment Healthcare (ALHC) insider sales under a Rule 10b5-1 plan?

Yes. The filing states the transactions were conducted under a Rule 10b5-1 trading plan adopted on 05/22/25. Such pre-arranged plans automate trading to reduce the influence of short-term information on insider transactions.

How many Alignment Healthcare (ALHC) shares did Dawn Christine Maroney gift and to whom?

She made bona fide gifts totaling 21,500 shares of Alignment Healthcare common stock. According to the filing, 20,000 shares were gifted to a family member and 1,500 shares to a charitable donor advised fund.

What is Dawn Christine Maroney’s remaining Alignment Healthcare (ALHC) shareholding after these transactions?

After the reported sale and gifts, Dawn Christine Maroney directly holds 977,313 shares of Alignment Healthcare common stock. This figure reflects her remaining position following all three Form 4 transactions.

Does the Form 4 for Alignment Healthcare (ALHC) show any option exercises or derivative transactions?

No derivative transactions or option exercises are listed in this Form 4. The filing only reports non-derivative common stock movements: one open-market sale of 30,000 shares and two bona fide gifts totaling 21,500 shares.